McKesson (MCK) Competitors

Cencora (NYSE:COR) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment, dividends and community ranking.

Do institutionals and insiders believe in COR or MCK?

97.5% of Cencora shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 10.8% of Cencora shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Is COR or MCK more profitable?

McKesson has a net margin of 0.82% compared to Cencora's net margin of 0.46%. Cencora's return on equity of 328.62% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.46%	328.62%	4.23%
McKesson	0.82%	-181.26%	5.34%

Does the MarketBeat Community favor COR or MCK?

McKesson received 230 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.26% of users gave McKesson an outperform vote while only 65.30% of users gave Cencora an outperform vote.

Company	Underperform	Outperform
Cencora	Outperform Votes 751 65.30%	Underperform Votes 399 34.70%
McKesson	Outperform Votes 981 74.26%	Underperform Votes 340 25.74%

Does the media prefer COR or MCK?

In the previous week, McKesson had 15 more articles in the media than Cencora. MarketBeat recorded 37 mentions for McKesson and 22 mentions for Cencora. McKesson's average media sentiment score of 1.17 beat Cencora's score of 1.13 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	16 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	27 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings & valuation, COR or MCK?

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$638.56M	87.26	$1.51B	$8.62	33.35
McKesson	$359.05B	0.25	$3.00B	$25.83	27.64

Do analysts recommend COR or MCK?

Cencora presently has a consensus price target of $306.91, indicating a potential upside of 6.76%. McKesson has a consensus price target of $694.38, indicating a potential downside of 2.74%. Given Cencora's stronger consensus rating and higher possible upside, equities analysts clearly believe Cencora is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.90
McKesson	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.87

Which has more risk and volatility, COR or MCK?

Cencora has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500.

Is COR or MCK a better dividend stock?

Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.4%. Cencora pays out 25.5% of its earnings in the form of a dividend. McKesson pays out 11.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has increased its dividend for 15 consecutive years and McKesson has increased its dividend for 17 consecutive years.

Summary

McKesson beats Cencora on 13 of the 22 factors compared between the two stocks.